An imbalance between oxidative stress and antioxidative capacity is thought to piay an important role in the development and progression of chronic obstructive pulmonary disease (COPD). To assess the lung oxidative status in patients with COPD, we studied whether exhaled hydrogen peroxide (H2O2) is increased in breath condensate of patients with stable COPD (n = 12, mean FEV1 51% pred) and in patients with exacerbated COPD (n = 19, actual FEVi 36% pred) compared with a healthy control group (n = 10, FEVi 108% pred). Expired breath condensate during 15 min of tidal breathing was collected by cooling. The concentration of H2O2 was measured spectrophotometrically by means of horse radish peroxidase-catalyzed oxidation of tetramethylbenzidine. Concentrations of H2O2 (mean ± SEM) were significantly elevated at 0.205 ± 0.054 nM in patients with stable COPD compared with 0.029 ± 0.012 n.M in the control group (p < 0.05) and were further increased to 0.600 ± 0.075 nM in patients with acutely exacerbated COPD (p < 0.001 compared with patients with stable COPD). Patients with pulmonary infiltrates on chest radiograph showed similar values compared with patients without obvious infiltrates. These findings demonstrate that patients with stable COPD exhibit increased oxidant production in the airways and that oxidant production increases further during exacerbations.
Reactive oxygen-derived species (ROS) have been implicated in the pathogenesis and pathophysiology o f tobacco smoke-induced chronic obstructive pulmonary disease (COPD) (I). This con tention is supported by several findings. Cigarette smoke is a rich .source o f oxidants. Smokers have increased numbers o f macro phages and neutrophils in their alveoli (2), and these cells are activated and produce increased amounts o f ROS (3, 4). Oxida tive inactivation of methionine residues o f a,-proteinase inhibi tor may contribute to the onset and progression of emphysema (5).
Production of ROS is likely to increase further during an acute exacerbation because of the accompanying increased numbers o f inflammatory cells in the lower airways (6) . In addition, alve olar macrophages (AM) in smokers with a recent lower respira-respect, exhalation of hydrogen peroxide (Hz0 2) is of potential interest. Hydrogen peroxide is a harmful ROS because it is rela tively stable, it can cross membranes due to its small size and its lack of charge, and it can generate the highly reactive hydroxyl radical in the presence of superoxide anions and iron (8) . Clini cally, increased levels o f exhaled H*Oj have been demonstrated in children with asthma (9) and in patients with adult respira tory distress syndrome and acute hypoxemic respiratory failure ( 
We hypothesized that an increased oxidative burden in the lungs of patients with COPD would be reflected in increased levels o f exhaled H 20 2. The present study was undertaken to answer two questions: 1) Is the concentration of exhaled Ha0 2 increased tory tract infection were found to release increased numbers of in patients with stable COPD compared with normal subjects, ROS (7) .
Direct in vivo evidence o f increased concentrations o f ROS in patients with COPD has not been provided, however. In this and 2) Are levels of exhaled HzOj increased even further during exacerbations of COPD? ( % Arterial blood gas obtained a fte r at least 30 m inutes o f b re a th in g a m b ie n t air.
n.m, = n o t measured.
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lecting system which was placed in ice. The collecting system was con nected to a 2 ml sterile plastic tube. In this way, approximately 1 ml of breath condensate was collected within 15 min of tidal breathing. The samples were immediately placed in liquid nitrogen. Measurements of H20 2 were performed within 6 h after sample collection, since prelimi nary data showed that H20 2 concentrations did not change during this period. The method described by Gallati and Pracht was applied (13). Briefly, 100 jj.1 of 420 |iM 3',3,5,5'-tetramethylbenzidine (dissolved in 0.42 M citrate buffer, pH 3.8) and 10 (4,1 of 52.5 U/ml of horseradish peroxidase (HRP; Sigma Chemicals) were added to 100 |xl of the con densate. The reaction proceeded for 20 min at room temperature. Sub sequently, the mixture was acidified to a pH of 1 with 10 |il of 18 N sulfuric acid. The reaction product was measured spectrophotometrically at 450 nm using an automated microplate reader (model EL312; Bio-Tek Instruments Inc.), The absorbance is directly proportional to the concentration of H20 2. The detection limit was approximately 0.1 (.iM H20 2. All samples were measured in duplicate; mean values were used for subsequent analysis.
Statistical analysis. Data between the three groups were compared using one-way analysis of variance followed by Duncan's multiple range test. A Wilcoxon test was performed to test differences between patients with or without pulmonary infiltrates. Spearman correlation tests were performed to detect a correlation between the concentration of exhaled H i02 and clinical markers of severity of the disease such as FEW and
Pao2. All values are presented as mean ± SEM; statistical significance was assumed at p < 0.05. 8, FEVj 47 ± 6% pred) exhaled 0.269 ± 0.068 (xM (current versus exsmokers, p = 0.094). No significant correlations were found between the levels of H20 2 and FEY* (r = 0.13) or Pao2 (r = 0.16) in patients with stable and unstable COPD.
DISCU SSIO N
This study shows increased H20 2 concentrations in exhaled breath condensate in patients with stable COPD, providing direct evi dence o f increased production o f ROS in the airways of these patients. A further increase was observed in patients with an ex acerbation.
Concentrations of H20 2 measured in exhaled breath conden sate may be considered as the net result of production versus scavenging o f H20 2. An increased production of H20 2 may be caused by an increased number of lung inflammatory cells and/or increased production of H20 2 by these cells (7) . An increased number of these cells have been found in the lungs of patients with stable COPD. Both bronchial lavage and bronchoalveolar lavage fluid obtained from smokers with COPD contained more neutrophils than found in fluid obtained from healthy nonsmok ers (14, 15) (3, 4, 7, 17) . Bron choalveolar lavage fluid from smokers contained increased num bers o f AM with higher densities, which produced more superox ide anion radicals (17). In addition, AM from smokers with a recent lower respiratory tract infection released increased quan tities o f H2O z (7) .
. Increased numbers of macrophages and T lympho cytes were present in the bronchial mucosa of patients with chronic bronchitis and airflow obstruction compared with healthy

RESULTS
nonsmokers (16). Exacerbations of chronic bronchitis inpatients with mild COPD (mean FEVi approximately 66% pred) were associated with increased numbers of eosinophils, neutrophils, and T lymphocytes in the bronchial wall (6). Indications of increased activation and production of ROS by these cells have been observed in smokers
The production of ROS may be reduced, at least in vitro, by medications such as f}2 sympathomimetic drugs and theophyl line (18) . Whether this effect also occurs in vivo is unknown. Nat ural protection against an increased concentration of H20 2 is provided by catalase and -of particular importance in the -glutathione. Only a few studies have addressed the antioxidative capacity of the lungs of smokers (4,15, 19) . Reduced activities of superoxide dismutase, glutathione S-transferase, and glutathione peroxidase were found in the AM of elderly smokers (4). In contrast, enhanced activities o f superoxide dismutase and catalase, but not of glutathione peroxidase, were shown in the AM of younger smokers (19) . Linden and colleagues (15) demon strated an increased concentration of total glutathione (free and disulfide bound) in bronchoalveolar lavage fluid obtained from patients with COPD who were current smokers. It is unknown whether this increase in total glutathione is caused by continued smoking or by COPD itself (i.e., also occurring in exsmokers).
In contrast to our findings, Sznajder and colleagues (10) found significantly higher concentrations o f exhaled H20 2 in patients with acute respiratory failure and pulmonary infiltrates compared with those without. These authors also noted that central ner vous system involvement in these patients increased exhaled H20 2 levels compared with those patients without involvement; more over, patients with infiltrates and sepsis exhaled higher levels o f H 20 2 than those without sepsis. Thus, the differences observed in the study by Sznajder and colleagues may not be attributed solely to the presence or absence of infiltrates.
The current smokers in the group with stable COPD tended to exhale lower concentrations of H 20 2 compared with the ex smokers. The number of patients studied, however, was too small to make any conclusions about the ef fects of smoking in this respect. In addition, bias may have occurred in our separation
